Clinical TrialsSearch results
Number of results: 198
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Efficacy evaluation of Overflow leak test by 30 mL intrathecal injection
- cerebrospinal fluid hypovolemia
- Nakai Eiichi
- 2023-01-12
Recruiting
- Evaluation of Overflow leak test
- intracranial hypotension
- Nakai Eiichi
- 2019-05-20
Recruiting
- Safety assessment of 20 mL intrathecal injection in CSF refill test
- cerebrospinal fluid hypovolemia
- Nakai Eiichi
- 2021-11-18
No Longer Recruiting
- Exploratory study on the usefulness of CSF refill test in cerebrospinal fluid hypovolemia
- cerebrospinal fluid hypovolemia
- Nakai Eiichi
- 2019-11-14
Other
- Exercise and Life Functioning in Patients with Congestive Heart Failure
; A Rehabilitation Cohort Study.
- Patients with congestive heart failure
- Nagoya University School of Health Sciences
- 2007-12-01
Other
- Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients
- Hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 03 executive committee
- 2005-08-12
Other
- Phase III Randomized Adjuvant Study of Chemotherapy in Node Positive Breast Cancer Patients -AC(Anthracycline-Cyclophosphamide) 4 cycles followed by Taxane 4 cycles (AC-Tac) versus Taxane 8 cycles and Paclitaxel versus Docetaxel-
- node positive breast cancer
- N-SAS BC 02 executive committee
- 2005-08-12
Other
- Paclitaxel plus cisplatin and concurrent radiation for unresectable, locally recurrent or remnant gastric cancer in the left upper abdomen – phase I study
- unresectable, locally recurrent or remnant gastric cancer
- Multi-modality therapy for gastric cancer study group
- 2005-09-22
Other
- Comparison of Automatic and Manual Threshold Testing
- Patient implanted with cardiac pacemaker
- Medtronic Japan Co., Ltd.
- 2008-10-28
No Longer Recruiting
- A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
- Schizophrenia
- Matsumaru Takehisa
- 2021-11-22